Description Usage Format References
A series of diagnostic studies from published meta-analyses (see references) assessing various diagnostic tests detecting CIN2+ in women with ASC-US cytology. This dataset includes ‘all’ published studies including studies that assessed only one diagnostic test without a comparator.
1 |
A data frame of 121 observations and 6 variables:
Study identifier
Diagnostic test identifier
Number of true positives
Number of false negatives
Number of true negatives
Number of false positives
Arbyn M, Buntinx F, Ranst MV, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. JNCI: Journal of the National Cancer Institute. 2004 Feb 18;96(4):280-93.
Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012 Nov 20;30:F88-99.
Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin<e2><80><90>Hirsch PP, Prendiville WJ. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. The Cochrane Library. 2013.
Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, Reuschenbach M, Belinson S, Belinson JL, Monsonego J. The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC<e2><80><90>US or LSIL cervical cytology: A meta<e2><80><90>analysis of the diagnostic accuracy. International journal of cancer. 2013 Jan 1;132(1):101-8.
Roelens J, Reuschenbach M, von Knebel Doeberitz M, Wentzensen N, Bergeron C, Arbyn M. p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities. Cancer cytopathology. 2012 Oct 25;120(5):294-307.
Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M. Triage of women with minor abnormal cervical cytology: Meta<e2><80><90>analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high<e2><80><90>risk human papillomavirus types. Cancer cytopathology. 2013 Dec 1;121(12):675-87.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.